Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more
Intelligent Bio Solutions Inc. (INBS) - Net Assets
Latest net assets as of September 2025: $3.43 Million USD
Based on the latest financial reports, Intelligent Bio Solutions Inc. (INBS) has net assets worth $3.43 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.04 Million) and total liabilities ($6.61 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.43 Million |
| % of Total Assets | 34.14% |
| Annual Growth Rate | N/A |
| 5-Year Change | -81.25% |
| 10-Year Change | N/A |
| Growth Volatility | 77.11 |
Intelligent Bio Solutions Inc. - Net Assets Trend (2017–2025)
This chart illustrates how Intelligent Bio Solutions Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Intelligent Bio Solutions Inc. (2017–2025)
The table below shows the annual net assets of Intelligent Bio Solutions Inc. from 2017 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $2.81 Million | -65.61% |
| 2024-06-30 | $8.18 Million | +121.95% |
| 2023-06-30 | $3.69 Million | -43.67% |
| 2022-06-30 | $6.55 Million | -56.38% |
| 2021-06-30 | $15.01 Million | +387.77% |
| 2020-06-30 | $-5.21 Million | -31.12% |
| 2019-06-30 | $-3.98 Million | -29.82% |
| 2018-06-30 | $-3.06 Million | +48.18% |
| 2017-06-30 | $-5.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Intelligent Bio Solutions Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6222139300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $73.23K | 2.44% |
| Other Comprehensive Income | $-327.94K | -10.95% |
| Other Components | $65.78 Million | 2195.63% |
| Total Equity | $3.00 Million | 100.00% |
Intelligent Bio Solutions Inc. Competitors by Market Cap
The table below lists competitors of Intelligent Bio Solutions Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Diversified Gateway Solutions Bhd
KLSE:0131
|
$6.51 Million |
|
Yuasa Battery (Thailand) Public Company Limited
BK:YUASA
|
$6.51 Million |
|
BIOMAXIMA SA ZY 1
F:944
|
$6.51 Million |
|
Korfez Gayrimenkul Yatirim
IS:KRGYO
|
$6.51 Million |
|
CXApp Inc.
NASDAQ:CXAI
|
$6.50 Million |
|
EV Nickel Inc
OTCGREY:EVNIF
|
$6.50 Million |
|
DTREF
PINK:DTREF
|
$6.50 Million |
|
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA
|
$6.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Intelligent Bio Solutions Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,329,350 to 2,996,136, a change of -5,333,214 (-64.0%).
- Net loss of 10,568,733 reduced equity.
- New share issuances of 4,589,866 increased equity.
- Other comprehensive income increased equity by 384,670.
- Other factors increased equity by 260,983.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.57 Million | -352.75% |
| Share Issuances | $4.59 Million | +153.19% |
| Other Comprehensive Income | $384.67K | +12.84% |
| Other Changes | $260.98K | +8.71% |
| Total Change | $- | -64.03% |
Book Value vs Market Value Analysis
This analysis compares Intelligent Bio Solutions Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.53x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | $-9.79 | $3.71 | x |
| 2018-06-30 | $-7.24 | $3.71 | x |
| 2019-06-30 | $-7.64 | $3.71 | x |
| 2020-06-30 | $-7.31 | $3.71 | x |
| 2021-06-30 | $28.92 | $3.71 | x |
| 2022-06-30 | $0.45 | $3.71 | x |
| 2023-06-30 | $1.89 | $3.71 | x |
| 2024-06-30 | $2.62 | $3.71 | x |
| 2025-06-30 | $0.57 | $3.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Intelligent Bio Solutions Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -352.75%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -346.23%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 2.75x
- Recent ROE (-352.75%) is below the historical average (-102.96%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $251.25K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.58 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.88 Million |
| 2020 | 0.00% | -1967.77% | 0.08x | 0.00x | $-3.20 Million |
| 2021 | -46.73% | -355.40% | 0.09x | 1.45x | $-8.54 Million |
| 2022 | -125.38% | 0.00% | 0.00x | 1.86x | $-8.97 Million |
| 2023 | -279.86% | -845.82% | 0.12x | 2.73x | $-11.01 Million |
| 2024 | -121.94% | -326.40% | 0.23x | 1.65x | $-10.99 Million |
| 2025 | -352.75% | -346.23% | 0.37x | 2.75x | $-10.87 Million |
Industry Comparison
This section compares Intelligent Bio Solutions Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $3.43 Million | 0.00% | 1.93x | $6.50 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |